BSE filing, NSE: SOMANYCERA. Summary written from the filing by ALFA Finder's alert engine.
Somany Ceramics Ltd: key numbers
- Share price
- ₹545.00
- Market cap
- ₹2,235 Cr
- Revenue (annual)
- ₹2,790 Cr
- Net profit (annual)
- ₹81.19 Cr
- P/E (TTM)
- 21.0×Sector 41.7×
- Promoter holding
- 55.20%+0.00% QoQ
- FII holding
- 2.88%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Somany Ceramics Ltd
All →Somany Ceramics Board Meeting Date
Somany Ceramics scheduled a board meeting on 4 Nov 2026 to consider Q2/H1 results. No other material agenda items are disclosed.
Somany Ceramics Acquisition Worth ₹58.8 Cr
Somany Ceramics extended the timeline for its proposed 49% investment in Siravit Ceramics Private Limited by three months, now expected by 8th January, 2027.
- Value
- ₹58.80 Cr
Somany Ceramics Earnings Call Transcript: Key Takeaways
Somany Ceramics delivered margin improvement despite flat volumes, driven by high capacity utilization and operational efficiencies. Management remains cautious on volume growth while aggressively investing in high-margin value-added segments and South India expansion.
- Call
- Guides 7% growth
Somany Ceramics Annual General Meeting
Somany Ceramics held its 58th Annual General Meeting on August 12, 2026. The meeting concluded after transacting ordinary and special business resolutions.
Somany Ceramics Investor Presentation: Key Takeaways
Somany Ceramics delivered strong Q1FY27 performance with 24% YoY revenue growth and EBITDA margin expansion to 11.6%. Focus remains on product premiumization and Southern market expansion.
Somany Ceramics Q1 FY27 Results: Net Profit ₹34.2 Cr, Up 368.5% YoY
Somany Ceramics Ltd reported revenue from operations of ₹749.6 Cr (+24.0% YoY) and net profit of ₹34.2 Cr (+368.5% YoY) for Q1 FY27.
- Key figure
- Net profit ₹34.2 Cr · +368.5% YoY
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.